Prime again dominates the ACA market

February 13, 2023

Once again, Prime Therapeutics (Prime) is the largest pharmacy benefit manager (PBM) serving the health insurance marketplace (HIM). According to the U.S. Department of Health and Human Services, more than 16.3 million people have enrolled for individual coverage under the Affordable Care Act (ACA). With 3.66 million HIM members, Prime serves 22% of the individual market.

In addition, Prime has 2.34 million HIM members in the small group marketplace. While total small group enrollment figures aren’t yet available, Prime estimates enrollment will again be around 9.4 million.

“Our Blue Plan owner-clients believe that serving the individual and small group market is part of their mission,” Steven Heavrin, senior director, HIM programs at Prime said. “As a result, Prime traditionally serves between 20% and 25% of the market.”

Prime’s 6 million HIM members in January 2023 is up from Prime’s 5.5 members in January 2022. Steven attributes the growth to several factors:

Prime’s recently announced acquisition of Magellan Rx Management (Magellan Rx) expands the HIM footprint even more. Prime added 40,000 additional members through Magellan Rx. Magellan Rx serves one health plan with a presence in the HIM market.

Blue commitment pays off

With no historical data, risk management and pricing were challenges when HIM was launched. Few plans entered the market in 2014. Many of them left in 2015 and 2016. Blue Plans stayed in. As the market matured, pricing adjustments settled down. Enrollees themselves aren’t jumping every year to the lowest premium option.

“That stability allows us to work closely with health plans to develop benefit design options that address the needs of their specific markets,” Heavrin said. “We’re studying designs that have worked in some markets, identifying best practices and bringing them to all our health plan clients. That’s contributing to our steady growth in the market.”

Related news


April 5, 2024

LISTEN NOW: Revolutionizing Healthcare: Prime & Capital Rx’s Game-Changing Alliance – Pharmacy Friends podcast

In this special episode of the Pharmacy Friends podcast, the CEOs of Prime Therapeutics, Mostafa Kamal, and Capital Rx, AJ Loiacono, join Michael Passanante, SVP of Marketing & Communications at Capital Rx, to share the story behind the strategic alliance between the organizations and their vision to reimagine pharmacy.


March 26, 2024

Announcing the new issue of Prime’s managed care report, featuring the latest trends and updates in medical and pharmacy benefits

Prime Therapeutics/Magellan Rx (Prime/MRx) today launched the spring edition of Magellan Rx Report…


March 19, 2024

Healthcare Businesswomen’s Association names Simone Ndujiuba and Jacki Shugart among 2024 Rising Stars 

Prime Therapeutics/Magellan Rx’s Director of Clinical Strategy and Innovation Simone Ndujiuba and Senior Program Manager Jacki Shugart honored for female leadership in the health care industry